Guy Handley
handleyg.bsky.social
Guy Handley
@handleyg.bsky.social
Transplant & Oncology ID at MD Anderson Cancer Center @mdanderson.bsky.social | UAB Heersink → Ochsner Clinic → UTHealth/MDACC | #IDSky #TxID | Views are my own
Reposted by Guy Handley
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine had no signs of relapse after three years.

Dr. Vinod Balachandran from @mskcancercenter.bsky.social joins us to discuss the results and what they could mean for cancer treatment.
A Vaccine For Pancreatic Cancer Continues To Show Promise
In a small trial, nearly half of pancreatic cancer patients who received an mRNA vaccine for the disease had no relapse three years later.
buff.ly
February 21, 2025 at 7:41 PM
Reposted by Guy Handley
#IDSky #AMR #PharmSky @idsainfo.bsky.social

🚨 On December 13, 2024, ASM and IDSA announced partnership to an annual conference on antimicrobial resistance starting in 2026! Cesar Arias, M.D., Ph.D., M.S., and Greg Moeck, Ph.D., are Co-Chairs of the Program Committee.

asm.org/Press-Releas...
ASM and IDSA to Launch New Conference on AMR
ASM and IDSA partner to create an annual AMR conference to explore the latest advances in antimicrobial drug discovery and development, mechanisms of resistance, pharmacological aspects and more.
asm.org
December 14, 2024 at 2:39 PM
Reposted by Guy Handley
We are thrilled to announce our 2025 USF ID Fellows! Welcome to USF ID family! #UStayForever #USF #GoBulls #IDSky #FellowshipMatch #Match #usfid
December 12, 2024 at 5:08 PM
Reposted by Guy Handley
Voting for the official 2025 #PanCANPurpleStride T-Shirt design has begun! 💜

To cast your vote, register for your local event at purplestride.org! Then, you'll receive an email to submit your pick. 📧 Voting ends on Wednesday, 12/18! 📅 Once you vote, make sure to raise $50+ to secure your shirt! ✅
December 11, 2024 at 5:37 PM
Reposted by Guy Handley
The annual #PanCANPurpleStride T-shirt is a BIG deal! 💜 Our Founder, Pam Acosta Marquardt, even had this special blanket created from all her past T-shirts! 😍

Starting TOMORROW, all registered Striders can cast their vote for their favorite 2025 T-shirt design 🗳 Register now at purplestride.org!
December 10, 2024 at 5:30 PM
Reposted by Guy Handley
Beyond happy with our match and our new class of fellows at UTHealth Houston
December 7, 2024 at 5:22 PM
Reposted by Guy Handley
Had a great chat with Tori Whitacre Martonicz from Infection Control Today on some of our recent research with genomic surveillance for healthcare outbreaks ⤵️

“Genomic Surveillance A New Frontier in Health Care Outbreak Detection”

#IDSky #MedSky

www.infectioncontroltoday.com/view/genomic...
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, ...
www.infectioncontroltoday.com
November 30, 2024 at 9:06 PM
Reposted by Guy Handley
📢 Brand new ID faculty position just posted @fredhutch.bsky.social in Seattle. Join our ID group that studies infections in immunocompromised hosts. The Emerald city has great academics, phenomenal facilities, outstanding collaborators - all in amazing surroundings.

apply.interfolio.com/159913
November 26, 2024 at 6:18 PM
Critical point for Infection Control. Also the difference between HZ and DZ can be very subtle and changes over time
November 23, 2024 at 12:50 PM
New practice guideline from NCCN this month including prophylaxis and CAR T-cell therapy updates. Very handy for clinicians and researchers!

pubmed.ncbi.nlm.nih.gov/39536464/
Prevention and Treatment of Cancer-Related Infections, Version 3.2024, NCCN Clinical Practice Guidelines in Oncology - PubMed
There is an increased risk of infection in patients with cancer that results in higher morbidity and mortality. Several risk factors can predispose these patients to infectious complications. Some suc...
pubmed.ncbi.nlm.nih.gov
November 21, 2024 at 12:25 AM
Reposted by Guy Handley
New virtual meeting for Immunocompromised Host Society: Addressing the Landscape of CMV Management in Transplant Recipients. Free to members or $25 plus a free membership for those not already members!

Forward on to your residents, fellows, grad students, and international colleagues

#TxID #CMV
November 18, 2024 at 7:50 PM
Reposted by Guy Handley
Good morning! It’s #AntibioticStewardshipWeek! Prompting awareness for the sensible use of antibiotics and using PO ABx when you can. 😊💊👨🏻‍⚕️ #IDSky #AMR
November 18, 2024 at 1:02 PM
Reposted by Guy Handley
Fantastic discussion yesterday with leaders in the field about NIH funding, clinical trials, national society/guidelines. Great for early career physicians and looking forward to the next meeting
We want to thank our expert panel for leading our first seminar this year "Building a Research Portfolio in Transplant ID!"

Look out for our upcoming series in the new year and message us if interested!!

1) Hepatitis B in SOT
2) Challenging Cases in TxID
3) CMV and SCT
November 16, 2024 at 1:52 PM
Reposted by Guy Handley
We want to thank our expert panel for leading our first seminar this year "Building a Research Portfolio in Transplant ID!"

Look out for our upcoming series in the new year and message us if interested!!

1) Hepatitis B in SOT
2) Challenging Cases in TxID
3) CMV and SCT
November 16, 2024 at 2:03 AM
Reposted by Guy Handley
Both letermovir & maribavir can be perpetrator or victim of a drug–drug interaction
🆕️🔥 #CPK
Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir & Maribavir: Guidance for Clinicians #idsky
✨️tables✨️ #bookmark
link.springer.com/article/10.1...
Drug–Drug Interaction Management with the Novel Anti-Cytomegalovirus Agents Letermovir and Maribavir: Guidance for Clinicians - Clinical Pharmacokinetics
Letermovir and maribavir have demonstrated efficacy in the prevention and treatment, respectively, of immunosuppressed patients with cytomegalovirus (CMV) infection and disease. These patients often h...
link.springer.com
November 15, 2024 at 3:54 PM
Reposted by Guy Handley
ID is a crucial specialty in medicine, yet applications for fellowship have declined.
In CIDJournal, Collin Telchik, MD, MPH, & colleagues evaluate interest in ID among med students & identify factors associated with interest/disinterest in ID @idsainfo.bsky.social
academic.oup.com/cid/advance-...
Gauging Medical Students’ Interests in Infectious Diseases
Summary: This study investigates medical students’ interest in infectious diseases, identifying critical factors shaping their career choices. The findings
academic.oup.com
November 14, 2024 at 5:35 PM
Reposted by Guy Handley